Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalJournal of Clinical Investigation
Volume133
StatePublished - May 15 2023

Cite this